Han-Gu Lee

Director Ejecutivo en RedoxBio Co., Ltd. .

Fortuna: 5 M $ al 30/04/2024

77 años

Health Technology

Consumer Services

Perfil

Han-Gu Lee is currently the Chairman & Co-Chief Executive Officer at RedoxBio Co., Ltd.
He previously held the position of Co-Chief Executive Officer & Director at DAE HWA PHARM Co., Ltd.
and HLB Pharmaceutical Co., Ltd.
He has an undergraduate and doctorate degree from Sungkyunkwan University.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
DAE HWA PHARM CO., LTD. 3.34%	05/04/2024	621 300 ( 3.34% )	5 M $	30/04/2024
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea. 0.41%	31/03/2023	100 000 ( 0.41% )	239 971 $	31/12/2020

Cargos activos de Han-Gu Lee

Empresas	Cargo	Inicio
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea.	Director Ejecutivo	-